1. Home
  2. SRDX

as 06-12-2024 4:00pm EST

$
-
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Medical/Dental Instruments

Nasdaq

Surmodics Inc is a provider of surface modification and in vitro diagnostic technologies to the healthcare industry. The company's mission is to improve the treatment and detection of disease by using its technology to provide solutions to difficult medical devices and diagnostic challenges. It has two reportable segments: Medical device unit; Manufacture of performance coatings, including surface modification coating technologies and the Vitro diagnostics unit; Manufacture of chemical and biological components used in in vitro diagnostic immunoassay and molecular tests within the diagnostic and biomedical research markets. Surmodics derives majority of its revenue from the Medical Device segment.

Founded: 1979 Country:
United States
United States
Employees: N/A City: EDEN PRAIRIE
Market Cap: 599.8M IPO Year: 1998
Target Price: $43.00 AVG Volume (30 days): 191.6K
Analyst Decision: Hold Number of Analysts: 4
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: 0.96 EPS Growth: N/A
52 Week Low/High: $24.56 - $42.36 Next Earning Date: 07-31-2024
Revenue: $142,963,000 Revenue Growth: 38.84%
Revenue Growth (this year): -5.43% Revenue Growth (next year): 11.87%

SRDX Daily Stock ML Predictions

Share on Social Networks: